Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada
Michael A. Campitelli, Susan E. Bronskill, Laura C. Maclagan, et al.
JAMA Network Open (2021) Vol. 4, Iss. 8, pp. e2118441-e2118441
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings
Joanne McDermid, Clive Ballard, Zunera Khan, et al.
International Journal of Geriatric Psychiatry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 25
Occurrence and fate of antidepressants in the aquatic environment: Insights into toxicological effects on the aquatic life, analytical methods, and removal techniques
Adarsh Singh, Duduku Saidulu, Ashok Kumar Gupta, et al.
Journal of environmental chemical engineering (2022) Vol. 10, Iss. 6, pp. 109012-109012
Closed Access | Times Cited: 31
Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network study
Hao Luo, Yi Chai, Sijia Li, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 10, pp. 807-817
Closed Access | Times Cited: 7
Algorithmic harms and digital ageism in the use of surveillance technologies in nursing homes
Clara Berridge, Alisa Grigorovich
Frontiers in Sociology (2022) Vol. 7
Open Access | Times Cited: 24
Behavioral symptoms, depression symptoms, and medication use in Michigan nursing home residents with dementia during COVID‐19
Antoinette B. Coe, Ana Montoya, Chiang‐Hua Chang, et al.
Journal of the American Geriatrics Society (2022) Vol. 71, Iss. 2, pp. 414-422
Open Access | Times Cited: 23
Selective Extraction of Diazepam and Its Metabolites from Urine Samples by a Molecularly Imprinted Solid-Phase Extraction (MISPE) Method
Ana Tejedor, Juan Carlos Bravo, Gema Paniagua González, et al.
Polymers (2024) Vol. 16, Iss. 5, pp. 635-635
Open Access | Times Cited: 6
National Trends in Antidepressant Use in Australian Residential Aged Care Facilities (2006–2019)
Georgina A. Hughes, Maria C. Inacio, Debra Rowett, et al.
Journal of the American Medical Directors Association (2024) Vol. 25, Iss. 6, pp. 104957-104957
Closed Access | Times Cited: 5
Resident-, prescriber-, and facility-level factors associated with antibiotic use in long-term care facilities: a systematic review of quantitative studies
Aurélie Bocquier, Berkehan Erkilic, Martin Babinet, et al.
Antimicrobial Resistance and Infection Control (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Long-Term Care Resident Health and Quality of Care During the COVID-19 Pandemic: A Synthesis Analysis of Canadian Institute for Health Information Data Tables
Luke Turcotte, Caitlin McArthur, Jeff Poss, et al.
Health Services Insights (2023) Vol. 16
Open Access | Times Cited: 13
The COVID-19 pandemic and the use of benzodiazepines and benzodiazepine-related drugs in Estonia: an interrupted time-series analysis
Katrin Kurvits, Karolin Toompere, Peeter Jaanson, et al.
Child and Adolescent Psychiatry and Mental Health (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
Eva Gerbier, Guillaume Favre, Fatima Tauqeer, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 9, pp. 5335-5335
Open Access | Times Cited: 17
Comparing quality of care outcomes between assisted living and nursing homes before and during the COVID‐19 pandemic
Matthias Hoben, David B. Hogan, Jeffrey W. Poss, et al.
Journal of the American Geriatrics Society (2023) Vol. 71, Iss. 11, pp. 3467-3479
Open Access | Times Cited: 10
A qualitative interview study of care home managers’ experiences of medicines optimisation for residents with dementia during the COVID-19 pandemic
Noora Abdulhafeedh Alsulami, Carmel Hughes, Heather E. Barry
BMJ Open (2025) Vol. 15, Iss. 1, pp. e091645-e091645
Open Access
Effects of Visitation Restriction on Antipsychotic Drug Use among Nursing Home Residents with ADRD during the COVID-19 Pandemic
Tingting Zhang, Christopher M. Santostefano, Anne Harris, et al.
Journal of the American Medical Directors Association (2025) Vol. 26, Iss. 4, pp. 105480-105480
Closed Access
COVID-19 Factors Associated With Medication Changes Among Nursing Home Residents With Dementia
Alison Rataj, Kate L. Lapane, Brian R. Ott, et al.
Journal of Applied Gerontology (2025)
Closed Access
Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPP
Christine Cunningham, Orla Macdonald, Andrea L. Schaffer, et al.
BMJ Mental Health (2025) Vol. 28, Iss. 1, pp. e301378-e301378
Open Access
Staff perceptions of the consequences of COVID‐19 on quality of dementia care for residents in Ontario long‐term care homes
Julia Kirkham, Carrie L. Shorey, Andrea Iaboni, et al.
International Journal of Geriatric Psychiatry (2022) Vol. 37, Iss. 6
Open Access | Times Cited: 16
Potential Unintended Consequences of Antipsychotic Reduction in Ontario Nursing Homes
Daniel A. Harris, Laura C. Maclagan, Andrea Iaboni, et al.
Journal of the American Medical Directors Association (2022) Vol. 23, Iss. 6, pp. 1066-1072.e7
Closed Access | Times Cited: 15
Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TPP cohort
Andrea L. Schaffer, Colm Andrews, Andrew D Brown, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 7, pp. e432-e442
Open Access | Times Cited: 3
On the Effect of COVID-19 on Drivers’ Behavior: A Survey Study
Erika Lopetrone, Francesco Biondi
Transportation Research Record Journal of the Transportation Research Board (2022) Vol. 2677, Iss. 4, pp. 742-750
Open Access | Times Cited: 14
Hospitalizations for Anorexia Nervosa during the COVID-19 Pandemic in France: A Nationwide Population-Based Study
Jean-Christophe Chauvet-Gélinier, Adrien Roussot, Bruno Vergès, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4787-4787
Open Access | Times Cited: 14
Did the COVID-19 Pandemic Affect the Use of Antipsychotics Among Nursing Home Residents With ADRD?
Di Yan, Helena Temkin‐Greener, Shubing Cai
American Journal of Geriatric Psychiatry (2022) Vol. 31, Iss. 2, pp. 124-140
Open Access | Times Cited: 14
What has changed in the pharmaceutical care after COVID-19: Pharmacists’ perspective
Zelal Kharaba, Sedq A. Moutraji, Rama A Al Khawaldeh, et al.
Pharmacy Practice (2022) Vol. 20, Iss. 2, pp. 01-08
Open Access | Times Cited: 13
Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: A population-based study
Laila Aboulatta, Payam Peymani, Christine M. Vaccaro, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0278072-e0278072
Open Access | Times Cited: 13
Psychotropic, Anticonvulsant, and Opioid Use in Assisted Living Residents Before and During the COVID-19 Pandemic
Colleen J. Maxwell, Hana Dampf, Wajd Alkabbani, et al.
Journal of the American Medical Directors Association (2023) Vol. 25, Iss. 1, pp. 121-129
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top